58
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
690156
Digital therapeutic devices to lower high blood pressure, reduce stress and induce sleep
- Erez Gavish: Co-Founder/CEO
About the Company
The original product, RESPeRATE, is the world’s only FDA-cleared, non-invasive hypertension treatment device. Used by hundreds of thousands of patients and is featured in the American Heart Association statement on non-pharmacological treatments.
RESPeRATE only “side effect” was that users were falling asleep as they used it. When 90% of users
reported that, beyond lowering their blood pressure, it also improved their sleep, we decided to turn the “side effect into a feature” and adapt the technology to help the millions who suffer from sleeplessness.
We went back to the drawing board and redesigned the effective device-guided breathing technology into a sleek smartphone-powered product.
